Skip to main content
Signal8

Danos Olivier

SEC insider (Form 3/4/5 filer). CIK 0001701180. Chief Scientific Officer at REGENXBIO Inc. (RGNX). 3 reported Form 4/5 transactions since Sep 2024; latest on Feb 1, 2025. Located in ROCKVILLE, MD.

Companies Danos Olivier has filed insider reports for

  • REGENXBIO Inc. (RGNX): Officer, Chief Scientific Officer
Danos Olivier profile photo

Danos Olivier

CIK: 0001701180

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)2 (66.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

REGENXBIO Inc. logo
RGNX

REGENXBIO Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • REGENXBIO Inc. logo
    RGNX

    REGENXBIO Inc.

    Feb 1, 2025
    Tax Payment
    Direct
    5.5K shares at avg. $8.07$44K
  • REGENXBIO Inc. logo
    RGNX

    REGENXBIO Inc.

    Jan 2, 2025
    Tax Payment
    Direct
    12.6K shares at avg. $7.73$98K
  • REGENXBIO Inc. logo
    RGNX

    REGENXBIO Inc.

    Jan 2, 2025
    Award
    Direct
    59.3K shares-

1-3 of 3